Desperate for a more stable energy supply, the state seems willing to give Elon Musk’s technology a try. He’ll have 100 days to deliver.
Category: Fremont, CA
Equities Research Analysts’ Upgrades for February, 7th (ACRX,…
According to Zacks, “AcelRx Pharmaceuticals, Inc., is a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of pain. The Company product candidates comprises: ARX-01 or the Sufentanil NanoTab PCA System; ARX-02 or the Sufentanil NanoTab BTP Management System; and ARX-03 or the Sufentanil/Triazolam NanoTab which are in their development stage.